Summary: This study evaluated the feasibility, safety, and effectiveness of postoperative adjuvant chemotherapy with docetaxel/cisplatin/S-1 (DCS) following S-1 therapy in the treatment of patients with stage III gastric cancer after curative gastrectomy.
Summary: This study compared the effectiveness and side effects of a single dose (Pegfilgrastim or PDL) or repeated six daily injections (Filgrastim or PDG) during chemotherapy in patients with breast cancer.
Summary: This study assessed the safety and effectiveness of biweekly trifluridine and tipiracil hydrochloride (TAS-102) with bevacizumab combination therapy for patients with metastatic colorectal cancer (mCRC).
Summary: This meta-analysis assessed the superiority of PEGylated granulocyte colony-stimulating factor (PEGylated G-CSF) as an alternative to granulocyte colony-stimulating factor (G-CSF) to improve chemotherapy-induced neutropenia (CIN) in breast cancer patients.
Summary: This study tested the safety and efficacy of using palbociclib to treat grade 3 neutropenia in patients with hormone receptor-positive metastatic breast cancer.
Summary: This study evaluated the usefulness of serum galactomannan (sGM) measurements in initiating and modifying antifungal therapy (AFT) in children with cancer and persistent high-risk febrile neutropenia (HRFN).
Summary: This study evaluated whether five days of filgrastim therapy was equivalent to 7/10 days for primary febrile neutropenia (FN) prophylaxis in patients with early breast cancer.
Summary: This study tested the safety and efficacy of using clofarabine, cytarabine, and mitoxantrone to treat patients with refractory/relapsed acute myeloid leukemia.
Summary: This case report discusses a 58-year-old man with treatment-resistant schizophrenia who developed hepatotoxicity and neutropenia after being treated with clozapine which was discontinued.
Summary: This study investigated the effectiveness and safety through postmarketing surveillance of trabectedin in patients with unresectable and relapsed soft-tissue sarcomas (STSs).
Summary: The purpose of the study was to compare efficacy and safety of dose-dense weekly paclitaxel versus 3- weekly carboplatin for the treatment of epithelial ovarian, fallopian tube, or primary peritoneal carcinoma.